Outcomes in antiretroviral-naive HIV-infected patients initiating therapy with TDF/FTC plus either atazanavir/r or another third recommended drug - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Conference Papers Journal of the International AIDS Society Year : 2010

Outcomes in antiretroviral-naive HIV-infected patients initiating therapy with TDF/FTC plus either atazanavir/r or another third recommended drug

Abstract

N.A

Domains

Infectious diseases
Fichier principal
Vignette du fichier
1758-2652-13-S4-P9.pdf (183.01 Ko) Télécharger le fichier
1758-2652-13-S4-P9.xml (7.33 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Format : Other

Ed. BMC  : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-00663714

Submitted on : Friday, January 27, 2012-2:14:15 PM

Last modification on : Wednesday, May 3, 2023-2:12:17 PM

Long-term archiving on: Saturday, April 28, 2012-2:31:11 AM

Download

Dates and versions

inserm-00663714 , version 1 (27-01-2012)

Identifiers

Cite

Eric Billaud, Jean-Marc Lacombe, Sophie Abgrall, Jade Ghosn, Odile Launay, et al.. Outcomes in antiretroviral-naive HIV-infected patients initiating therapy with TDF/FTC plus either atazanavir/r or another third recommended drug. Tenth International Congress on Drug Therapy in HIV Infection, Nov 2010, Glasgow, United Kingdom. pp.P9, ⟨10.1186/1758-2652-13-S4-P9⟩. ⟨inserm-00663714⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM UNIV-PARIS7 UPMC HCL HEH UNIV-PARIS-SACLAY SORBONNE-UNIVERSITE SU-MEDECINE CIC1417
4797 View
241 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More